Document is current
Any future updates will be listed below
-
Authors
O’Sullivan, Donnchadh
Mayourian, Joshua
Anjewierden, Scott
Liu, Kan
Attia, Zachi Itzhak
Lopez-Jimenez, Francisco
Friedman, Paul A.
Doan, Tam
Patterson, Lance
Dugan, Jennifer
Johnson, Jonathan N.
Valdes, Santiago
Penny, Daniel J.
Triedman, John K.
Kim, Jeffrey J.
Niaz, Talha
Morris, Shaine A.
Madhavan, Malini
- License Information
-
More Information
Article History
Received: 19 October 2025
Accepted: 29 January 2026
First Online: 26 February 2026
Competing interests
: D.O’S., J.M., S.A., K.L., T.D., L.P., J.D., J.N.J., S.V., D.J.P., J.J.K., J.T., S.A.M., T.N., and M.M. report no conflicts of interest. I.Z.A. holds an ownership interest in Xai.health and serves as an advisor to Anumana.ai and AliveCor. F.L.-J. acts as an advisor to Anumana, receives royalties as a patent beneficiary from Anumana, consults for Kento, and serves as an advisor to Novo Nordisk and Wiseacre. P.A.F. has financial interests with Anumana, Eko Health, and AliveCor.
